PMDA
- Application: Isentress
- Local brand name: Isentress
- Status: approved
Raltegravir plus Truvada (Raltegravir plus Truvada) regulatory status in Japan.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA has authorised it.
Community Research Initiative of New England is the originator. The local marketing authorisation holder may differ — check the official source linked above.